ECT in genetically confirmed Huntington's disease.
The authors report successful ECT treatment of a severely depressed man with genetically confirmed Huntington's disease. He responded well to treatment and showed no abnormal movements or worsening in his cognitive status.
Lewis
C F
CF
University of Michigan Department of Psychiatry, Ann Arbor 48109, USA.
DeQuardo
J R
JR
Tandon
R
R
D000368:Aged; D000483:Alleles; D000657:Amoxapine / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D004565:Electroconvulsive Therapy; D005784:Gene Amplification; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006816:Huntington Disease / Q000235:genetics* / Q000523:psychology; D008297:Male; D011619:Psychotropic Drugs / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D018911:Trinucleotide Repeats
D000657:Amoxapine; D006220:Haloperidol; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors